Ophthalmics
Our ophthalmic portfolio includes below products.
| Product | Strength |
| Olopatadine Hcl | 0.1 % ophthalmic solution |
| Olopatadine Hcl | 0.2% ophthalmic solution |
US: Filed 2 ANDAs, 1 approved, 1 launched commercial, 1 under review
Canada: 2 Filed, 2 approved, 2 Commercial
Emerging Market: 4 Filed, 1 approved, 3 under review
EU/UK: 1 Filed, 1 approved, 1 commercial (4 MAs of ophthalmic products)
For more information about our existing portfolio and our pipeline products please e-mail us at info@usv.in
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.